4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Onconetix, Inc. (ONCO) operates in the Biotechnology industry and is headquartered in Cincinnati, United States with about 2 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, ONCO reported $1M in revenue and ($14M) in net income.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Interactive charts & full statements → Open the ONCO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $2M | $0M | $0M | — |
| Gross Profit | $1M | $1M | ($1M) | $0M | — |
| Operating Income (EBIT) | ($6M) | ($10M) | ($18M) | ($14M) | — |
| Net Income | ($14M) | ($59M) | ($37M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($1M) | ($2M) | ($1M) | ($2M) | — |
| Net Income | ($4M) | $6M | ($9M) | ($2M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $25M | $28M | $88M | $26M | — |
| Total Liabilities | $9M | $19M | $86M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ONCO viewer.
About TickerBase · Data methodology & sources